Fluorescent in situ hybridization on tissue microarrays: challenges and solutions - PubMed (original) (raw)

Review

Fluorescent in situ hybridization on tissue microarrays: challenges and solutions

Lindsay A Brown et al. J Mol Histol. 2007 May.

Abstract

Tissue microarray (TMA) technology has provided a high throughput means of evaluating potential biomarkers and therapeutic targets in archival pathological specimens. TMAs facilitate the rapid assessment of molecular alterations in hundreds of different tumours on a single slide. Sections from TMAs can be used for any in situ tissue analysis, including fluorescent in situ hybridization (FISH). FISH is a molecular technique that detects numerical and structural abnormalities in both metaphase chromosomes and interphase nuclei. FISH is commonly used as a prognostic and diagnostic tool for the detection of translocations and for the assessment of gene deletion and amplification in tumours. Performing FISH on TMAs enables researchers to determine the clinical significance of specific genetic alterations in hundreds of highly characterized tumours. The use of FISH on archival paraffin embedded tissues is technically demanding and becomes even more challenging when applied to paraffin embedded TMAs. The problems encountered with FISH on TMAs, including probe preparation, hybridization, and potential applications of FISH, will be addressed in this review.

PubMed Disclaimer

Similar articles

• The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts.
  Tubbs RR, Pettay J, Barry TS, Swain E, Loftus M, Cook JR, Skacel M, Paine G, Roche P, Grogan T. Tubbs RR, et al. J Mol Histol. 2007 May;38(2):159-65. doi: 10.1007/s10735-006-9066-1. Epub 2006 Nov 9. J Mol Histol. 2007. PMID: 17094016
• Improved procedure for fluorescence in situ hybridization on tissue microarrays.
  Andersen CL, Hostetter G, Grigoryan A, Sauter G, Kallioniemi A. Andersen CL, et al. Cytometry. 2001 Oct 1;45(2):83-6. doi: 10.1002/1097-0320(20011001)45:2<83::aid-cyto1149>3.0.co;2-p. Cytometry. 2001. PMID: 11590619
• Fluorescence in situ hybridization analysis of formalin fixed paraffin embedded tissues, including tissue microarrays.
  Summersgill BM, Shipley JM. Summersgill BM, et al. Methods Mol Biol. 2010;659:51-70. doi: 10.1007/978-1-60761-789-1_4. Methods Mol Biol. 2010. PMID: 20809303
• Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.
  Bubendorf L, Nocito A, Moch H, Sauter G. Bubendorf L, et al. J Pathol. 2001 Sep;195(1):72-9. doi: 10.1002/path.893. J Pathol. 2001. PMID: 11568893 Review.
• Perspectives in tissue microarrays.
  Braunschweig T, Chung JY, Hewitt SM. Braunschweig T, et al. Comb Chem High Throughput Screen. 2004 Sep;7(6):575-85. doi: 10.2174/1386207043328445. Comb Chem High Throughput Screen. 2004. PMID: 15379629 Review.

Cited by

• Ammosamides A and B target myosin.
  Hughes CC, MacMillan JB, Gaudêncio SP, Fenical W, La Clair JJ. Hughes CC, et al. Angew Chem Int Ed Engl. 2009;48(4):728-32. doi: 10.1002/anie.200804107. Angew Chem Int Ed Engl. 2009. PMID: 19097126 Free PMC article. No abstract available.
• Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.
  FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A, Fazli L, Rajput AB, Gleave ME, Cox ME, Ostrander EA, Stanford JL, Huntsman DG. FitzGerald LM, et al. BMC Cancer. 2008 Aug 11;8:230. doi: 10.1186/1471-2407-8-230. BMC Cancer. 2008. PMID: 18694509 Free PMC article.
• Numerical and structural genomic aberrations are reliably detectable in tissue microarrays of formalin-fixed paraffin-embedded tumor samples by fluorescence in-situ hybridization.
  Horn H, Bausinger J, Staiger AM, Sohn M, Schmelter C, Gruber K, Kalla C, Ott MM, Rosenwald A, Ott G. Horn H, et al. PLoS One. 2014 Apr 14;9(4):e95047. doi: 10.1371/journal.pone.0095047. eCollection 2014. PLoS One. 2014. PMID: 24733537 Free PMC article.
• Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
  Fadlelmola FM, Zhou M, de Leeuw RJ, Dosanjh NS, Harmer K, Huntsman D, Lam WL, Banerjee D. Fadlelmola FM, et al. Mol Cancer. 2008 Jan 7;7:2. doi: 10.1186/1476-4598-7-2. Mol Cancer. 2008. PMID: 18179710 Free PMC article.
• ESR1 gene amplification in breast cancer: a common phenomenon?
  Brown LA, Hoog J, Chin SF, Tao Y, Zayed AA, Chin K, Teschendorff AE, Quackenbush JF, Marioni JC, Leung S, Perou CM, Neilsen TO, Ellis M, Gray JW, Bernard PS, Huntsman DG, Caldas C. Brown LA, et al. Nat Genet. 2008 Jul;40(7):806-7; author reply 810-2. doi: 10.1038/ng0708-806. Nat Genet. 2008. PMID: 18583964 Free PMC article. No abstract available.

References

1. 1. J Mol Biol. 1977 Jun 15;113(1):237-51 - PubMed
2. 1. Gynecol Oncol. 2006 Feb;100(2):264-70 - PubMed
3. 1. Cytometry. 2001 Oct 1;45(2):83-6 - PubMed
4. 1. Cancer Res. 2006 Apr 1;66(7):3396-400 - PubMed
5. 1. Prenat Diagn. 2000 Mar;20(3):215-20 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database